1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Pseudoephedrine (hydrochloride; sulfate) |
| brand | String | Sudafed (IR, 12-hour, 24-hour); many combination products including Claritin-D, Allegra-D, Zyrtec-D, Mucinex-D |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Decongestants|Decongestant]] • [[:Category:Sympathomimetics|Sympathomimetic (indirect-acting)]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000017-QINU`"', '"`UNIQ--vote-00000018-QINU`"', '"`UNIQ--vote-00000019-QINU`"', '"`UNIQ--vote-0000001A-QINU`"' |
| starting_dose | String | IR: 60 mg PO every 4-6 hours. 12-hour ER: 120 mg PO every 12 hours. 24-hour ER: 240 mg PO once daily. Pediatric: weight-based |
| preparations | String | IR tablets 30, 60 mg; 12-hour ER tablets 120 mg; 24-hour ER tablets 240 mg; oral liquid; multiple combination products with antihistamines, NSAIDs, or expectorants |
| fda_max | String | 240 mg/day |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | 30-60 minutes |
| duration | String | 4-6 hours (IR); 12-24 hours (ER) |
| halflife | String | 9-16 hours (pH-dependent: acidic urine shortens, alkaline urine substantially extends)'"`UNIQ--ref-0000001B-QINU`"' |
| bioavailability | String | ~90% (oral, low first-pass)'"`UNIQ--ref-0000001C-QINU`"' |
| pregnancy | String | Some controversial signal for first-trimester gastroschisis association in observational studies; limited use is generally considered acceptable after the first trimester.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | '''[[USLegal:Behind-the-counter|Behind-the-counter]] in US''' under the Combat Methamphetamine Epidemic Act 2005: purchase restricted to ≤3.6 g/day and ≤9 g/30 days, with photo ID, logbook signature, and quantity logging required. Several states schedule higher than federal |
